Descriptor English: | Botulinum Toxins, Type A | ||||||
Descriptor Spanish: |
Toxinas Botulínicas Tipo A
| ||||||
Descriptor Portuguese: | Toxinas Botulínicas Tipo A | ||||||
Descriptor French: | Toxines botuliniques de type A | ||||||
Entry term(s): |
Botox Botulinum A Toxin Botulinum Neurotoxin A Botulinum Neurotoxin Type A Botulinum Toxin A Botulinum Toxin Type A Clostridium Botulinum Toxin Type A Clostridium botulinum A Toxin Meditoxin Neuronox Neurotoxin A, Botulinum Oculinum Onabotulinumtoxin A OnabotulinumtoxinA Toxin A, Botulinum Toxin, Botulinum A Vistabel Vistabex |
||||||
Tree number(s): |
D08.811.277.656.300.480.153.100 D08.811.277.656.675.374.153.100 D12.776.097.156.100 D23.946.123.179.050 |
||||||
RDF Unique Identifier: | https://id.nlm.nih.gov/mesh/D019274 | ||||||
Scope note: | A serotype of botulinum toxins that has specificity for cleavage of SYNAPTOSOMAL-ASSOCIATED PROTEIN 25. |
||||||
Annotation: | /antag permitted but consider also BOTULINUM ANTITOXIN |
||||||
Allowable Qualifiers: |
AD administration & dosage AE adverse effects AG agonists AI antagonists & inhibitors AN analysis BI biosynthesis BL blood CF cerebrospinal fluid CH chemistry CL classification CS chemical synthesis DE drug effects EC economics GE genetics HI history IM immunology IP isolation & purification ME metabolism PD pharmacology PH physiology PK pharmacokinetics PO poisoning RE radiation effects SD supply & distribution ST standards TO toxicity TU therapeutic use UL ultrastructure UR urine |
||||||
Pharm Action: |
Neuromuscular Agents Neurotoxins Acetylcholine Release Inhibitors |
||||||
Registry Number: | EC 3.4.24.69 | ||||||
Previous Indexing: |
Botulinum Toxins (1982-1996) |
||||||
Public MeSH Note: | 2011; see BOTULINUM TOXIN TYPE A 1997-2010, see BOTULINUM TOXINS 1983-1996, ONABOTULINUMTOXINA was indexed BOTULINIUM TOXINS, TYPE A 1997-2018 |
||||||
History Note: | 2011 (1997) |
||||||
DeCS ID: | 33081 | ||||||
Unique ID: | D019274 | ||||||
Documents indexed in the Virtual Health Library (VHL): | Click here to access the VHL documents | ||||||
Date Established: | 1997/01/01 | ||||||
Date of Entry: | 1996/06/10 | ||||||
Revision Date: | 2020/05/27 |
-
-
CHEMICALS AND DRUGS
Enzymes and Coenzymes [D08]Enzymes and Coenzymes -
CHEMICALS AND DRUGS
Enzymes and Coenzymes [D08]Enzymes and Coenzymes -
CHEMICALS AND DRUGS
Amino Acids, Peptides, and Proteins [D12]Amino Acids, Peptides, and Proteins -
CHEMICALS AND DRUGS
Biological Factors [D23]Biological Factors
|
Botulinum Toxins, Type A
- Preferred
Neuronox
- Narrower
Meditoxin
- Narrower
Oculinum
- Narrower
Vistabel
- Related but not broader or narrower
Vistabex
- Broader
Botox
- Related but not broader or narrower
OnabotulinumtoxinA
- Related but not broader or narrower
Concept UI |
M0028703 |
Scope note | A serotype of botulinum toxins that has specificity for cleavage of SYNAPTOSOMAL-ASSOCIATED PROTEIN 25. |
Preferred term | Botulinum Toxins, Type A |
Entry term(s) |
Botulinum A Toxin Botulinum Neurotoxin A Botulinum Neurotoxin Type A Botulinum Toxin A Botulinum Toxin Type A Clostridium Botulinum Toxin Type A Clostridium botulinum A Toxin Neurotoxin A, Botulinum Toxin A, Botulinum Toxin, Botulinum A |
Concept UI |
M000638652 |
Preferred term | Neuronox |
Concept UI |
M0541761 |
Preferred term | Meditoxin |
Concept UI |
M0373308 |
Preferred term | Oculinum |
Concept UI |
M000638086 |
Preferred term | Vistabel |
Concept UI |
M000644591 |
Preferred term | Vistabex |
Concept UI |
M0373309 |
Preferred term | Botox |
Concept UI |
M0538304 |
Preferred term | OnabotulinumtoxinA |
Entry term(s) |
Onabotulinumtoxin A |
We want your feedback on the new DeCS / MeSH website
We invite you to complete a survey that will take no more than 3 minutes.
Go to survey